遺伝子発現の世界市場レポート 2025

遺伝子発現の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.2％で202億5,000万米ドルに成長します。予測期間の成長は、空間トランスクリプトミクスの出現、エピゲノム研究の増加、世界の健康イベントとパンデミックへの備え、非コードRNA探索への注力、免疫療法研究における利用の増加などに起因します。予測期間における主な動向には、シングルセルRNAシーケンス、次世代シーケンスの進歩、マルチオミクスデータの統合、遺伝子編集技術の進歩、リキッドバイオプシーの開発、創薬における空間オミクスなどがあります。

精密医療が重視されるようになったことで、今後遺伝子発現市場の拡大が見込まれます。精密医療は、個人の遺伝子やタンパク質に関する情報を病気の診断、予防、治療に活用します。遺伝子発現は、さまざまな病態の組織における遺伝子や転写物の測定や比較を通じて、正常な機能や生理的調節の異常を特定し、患者中心の治療を可能にすることで、精密医療において重要な役割を果たしています。例えば、2023年2月、米国の非営利団体である個別化医療連合（PMC）の報告書によると、2021年に新たに承認された新規分子医薬品（NME）の35％が個別化医薬品でした。2022年の新規承認は12件で、過去8年間一貫して新薬承認の4分の1以上を維持しており、10年前の10％未満から大幅に増加しています。このように、精密医療への注目の高まりが遺伝子発現市場を後押ししています。

慢性疾患の増加は、今後数年間の遺伝子発現市場の成長を促進すると予想されます。慢性疾患とは、一般的に3カ月以上続く長期的な病状です。遺伝子発現分析は、慢性疾患の背景にある分子メカニズムを理解し、潜在的なバイオマーカーを特定し、標的療法を開発するために使用されます。例えば、2022年6月、英国を拠点とするがん慈善団体であるMacmillan Cancer Supportのデータによると、がんを患う人の数は2022年に300万人に達し、英国では2025年までに約350万人、2030年までに400万人に増加すると予測されています。このように、慢性疾患の増加は遺伝子発現市場の成長に拍車をかけると思われます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝子発現PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の遺伝子発現市場：成長率分析
• 世界の遺伝子発現市場の実績：規模と成長, 2019-2024
• 世界の遺伝子発現市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝子発現総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子発現市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キットと試薬
• DNAチップまたはマイクロアレイ
• その他の製品
• 世界の遺伝子発現市場：プロセス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• サンプル収集
• 精製
• cDNAの合成と変換
• PCR分析
• データ分析と解釈
• 世界の遺伝子発現市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• RNA実験
• プロモーター分析
• タンパク質の発現と翻訳後修飾の解析
• 世界の遺伝子発現市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品の発見と開発
• 臨床診断
• バイオテクノロジーと微生物学
• その他の用途
• 世界の遺伝子発現市場、キットと試薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• RNA分離キット
• cDNA合成キット
• qPCRキット
• 逆転写キット
• その他の試薬
• 世界の遺伝子発現市場DNAチップまたはマイクロアレイの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 発現マイクロアレイ
• ジェノタイピングマイクロアレイ
• 比較ゲノムハイブリダイゼーションアレイ
• 世界の遺伝子発現市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析用ソフトウェア
• 実験器具
• 消耗品

第7章 地域別・国別分析

• 世界の遺伝子発現市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝子発現市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子発現市場：競合情勢
• 遺伝子発現市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PerkinElmer Inc.
• GE Healthcare
• F Hoffmann-La Roche Ltd
• Oxford Gene Technology IP Limited
• Promega Corporation
• OriGene Technologies Inc.
• Luminex Corporation
• Takara Bio Inc.
• Danaher Corporation
• ELITechGroup
• Biocartis Group NV
• Integragen SA
• Oxford Nanopore Technologies Limited
• Phalanx Biotech Group
• Roche Holding AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子発現市場2029：新たな機会を提供する国
• 遺伝子発現市場2029：新たな機会を提供するセグメント
• 遺伝子発現市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gene expression is the process through which the information encoded in a gene is utilized to produce a functional product, typically a protein. This process directs the assembly of protein molecules, and the resulting proteins play a critical role in determining cell function.

The primary products associated with gene expression include kits and reagents, DNA chips or microarrays, and others. Kits and reagents are testing kits employed to detect specific substances either in a laboratory or in the field. The major processes involved in gene expression include sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation. Techniques related to gene expression encompass RNA expression, promoter analysis, protein expression, and posttranslational modification analysis. These methods find applications in various fields such as drug discovery and development, clinical diagnostics, biotechnology, microbiology, and other related areas.

The gene expression market research report is one of a series of new reports from The Business Research Company that provides gene expression market statistics, including gene expression industry global market size, regional shares, competitors with a gene expression market share, detailed gene expression market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. This gene expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene expression market size has grown rapidly in recent years. It will grow from $11.55 billion in 2024 to $12.79 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increasing focus on precision medicine, rise in cancer research and biomarker discovery, application in disease diagnosis and prognosis, integration with systems biology approaches, drug discovery and development needs.

The gene expression market size is expected to see rapid growth in the next few years. It will grow to $20.25 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to emergence of spatial transcriptomics, rise in epigenomic studies, global health events and pandemic preparedness, focus on non-coding rna exploration, increased utilization in immunotherapy research. Major trends in the forecast period include single-cell RNA sequencing, advancements in next-generation sequencing, integration of multi-omics data, advancements in gene editing technologies, liquid biopsy development, and spatial omics in drug discovery.

The growing emphasis on precision medicine is anticipated to drive the expansion of the gene expression market in the future. Precision medicine utilizes information about an individual's genes or proteins to diagnose, prevent, or treat diseases. Gene expression plays a vital role in precision medicine by identifying abnormalities in normal function and physiological regulation through the measurement and comparison of genes and transcripts in tissues across different medical conditions, enabling patient-centric treatment. For example, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that personalized medicines constituted 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently maintained at least a quarter of new drug approvals over the past eight years, marking a significant rise from under 10% a decade earlier. Thus, the increased focus on precision medicine is propelling the gene expression market.

The increase in chronic diseases is expected to drive the growth of the gene expression market in the coming years. Chronic diseases are long-term medical conditions that last for an extended period, typically three months or longer. Gene expression analysis is employed in the context of chronic diseases to comprehend the molecular mechanisms behind these conditions, identify potential biomarkers, and develop targeted therapies. For example, in June 2022, data from Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Thus, the increase in chronic diseases will fuel the growth of the gene expression market.

Technological advancement stands out as a notable trend in the gene expression market, with major companies progressing towards RNA gene expression technology. For instance, in September 2022, Enzo Biochem, Inc., introduced AMPIVIEW, a new platform leveraging RNA gene expression technology for superior sensitivity in detecting and visualizing biomarkers in cells and tissue samples, specifically targeting HPV and SARS-CoV-2.

Major companies in the gene expression market are concentrating on innovative product development, such as gene detection assays, to gain a competitive edge and enhance revenue. Gene detection assays involve methods for identifying and quantifying the presence of genetic molecules, offering insights into the activity and abundance of specific genes. In January 2023, Bio-Techne Corporation expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This assay allows simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution.

In January 2023, Qiagen NV, a molecular testing solutions company based in Germany, acquired Verogen for an undisclosed sum. This acquisition allows Qiagen to fully access Verogen's innovative GEDmatch database and GEDmatch PRO portal, as well as exclusive distribution rights for the MiSeq sequencer specifically designed for forensic applications. Verogen is a US-based developer of DNA-based biometric human identification products.

Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gene expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene expression market includes revenues earned by entities by providing services such as transcription, mRNA processing, non-coding RNA maturation, RNA export, translation, folding, translocation, and protein transport. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Expression Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene expression market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene expression ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene expression market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Kits And Reagents; DNA Chip Or Microarray; Other Products
• 2) By Process: Sample Collection; Purification; cDNA Synthesis And Conversion; PCR Analysis; Data Analysis And Interpretation
• 3) By Technique: RNA Exp; Promoter Analysis; Protein Exp. And Posttranslational Modification Analysis
• 4) By Application: Drug Discovery And Development; Clinical Diagnostics; Biotechnology And Microbiology; Other Applications
• Subsegments:
• 1) By Kits And Reagents: RNA Isolation Kits; cDNA Synthesis Kits; qPCR Kits; Reverse Transcription Kits; Other Reagents
• 2) By DNA Chip Or Microarray: Expression Microarrays; Genotyping Microarrays; Comparative Genomic Hybridization Arrays;
• 3) By Other Products: Software For Data Analysis; Lab Instruments; Consumables
• Companies Mentioned: Thermo Fisher Scientific Inc.; Qiagen NV; Illumina Inc.; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Expression Market Characteristics

3. Gene Expression Market Trends And Strategies

4. Gene Expression Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Gene Expression Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Expression PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Expression Market Growth Rate Analysis
• 5.4. Global Gene Expression Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Expression Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Expression Total Addressable Market (TAM)

6. Gene Expression Market Segmentation

• 6.1. Global Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Reagents
• DNA Chip Or Microarray
• Other Products
• 6.2. Global Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Collection
• Purification
• cDNA Synthesis And Conversion
• PCR Analysis
• Data Analysis And Interpretation
• 6.3. Global Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA Exp
• Promoter Analysis
• Protein Exp. And Posttranslational Modification Analysis
• 6.4. Global Gene Expression Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Development
• Clinical Diagnostics
• Biotechnology And Microbiology
• Other Applications
• 6.5. Global Gene Expression Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA Isolation Kits
• cDNA Synthesis Kits
• qPCR Kits
• Reverse Transcription Kits
• Other Reagents
• 6.6. Global Gene Expression Market, Sub-Segmentation Of DNA Chip Or Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Expression Microarrays
• Genotyping Microarrays
• Comparative Genomic Hybridization Arrays
• 6.7. Global Gene Expression Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software For Data Analysis
• Lab Instruments
• Consumables

7. Gene Expression Market Regional And Country Analysis

• 7.1. Global Gene Expression Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Expression Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Expression Market

• 8.1. Asia-Pacific Gene Expression Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Expression Market

• 9.1. China Gene Expression Market Overview
• 9.2. China Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Expression Market

• 10.1. India Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Expression Market

• 11.1. Japan Gene Expression Market Overview
• 11.2. Japan Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Expression Market

• 12.1. Australia Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Expression Market

• 13.1. Indonesia Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Expression Market

• 14.1. South Korea Gene Expression Market Overview
• 14.2. South Korea Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Expression Market

• 15.1. Western Europe Gene Expression Market Overview
• 15.2. Western Europe Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Expression Market

• 16.1. UK Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Expression Market

• 17.1. Germany Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Expression Market

• 18.1. France Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Expression Market

• 19.1. Italy Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Expression Market

• 20.1. Spain Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Expression Market

• 21.1. Eastern Europe Gene Expression Market Overview
• 21.2. Eastern Europe Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Expression Market

• 22.1. Russia Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Expression Market

• 23.1. North America Gene Expression Market Overview
• 23.2. North America Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Expression Market

• 24.1. USA Gene Expression Market Overview
• 24.2. USA Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Expression Market

• 25.1. Canada Gene Expression Market Overview
• 25.2. Canada Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Expression Market

• 26.1. South America Gene Expression Market Overview
• 26.2. South America Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Expression Market

• 27.1. Brazil Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Expression Market

• 28.1. Middle East Gene Expression Market Overview
• 28.2. Middle East Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Expression Market

• 29.1. Africa Gene Expression Market Overview
• 29.2. Africa Gene Expression Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Expression Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Expression Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Expression Market Competitive Landscape And Company Profiles

• 30.1. Gene Expression Market Competitive Landscape
• 30.2. Gene Expression Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Expression Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. GE Healthcare
• 31.3. F Hoffmann-La Roche Ltd
• 31.4. Oxford Gene Technology IP Limited
• 31.5. Promega Corporation
• 31.6. OriGene Technologies Inc.
• 31.7. Luminex Corporation
• 31.8. Takara Bio Inc.
• 31.9. Danaher Corporation
• 31.10. ELITechGroup
• 31.11. Biocartis Group NV
• 31.12. Integragen SA
• 31.13. Oxford Nanopore Technologies Limited
• 31.14. Phalanx Biotech Group
• 31.15. Roche Holding AG

32. Global Gene Expression Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Expression Market

34. Recent Developments In The Gene Expression Market

35. Gene Expression Market High Potential Countries, Segments and Strategies

• 35.1 Gene Expression Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Expression Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Expression Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer